Kate Didio Joins the Clinical Team at Extend Biosciences

Kate Didio, RN MBA, has joined Extend Biosciences as Clinical Program Lead, and will be responsible for all of the clinical operations and monitoring for the Phase 1 trial of EXT608. Ms. Didio has over 25 years of experience in clinical operations for biotech and pharmaceutical companies in multiple therapeutic areas, including pulmonary and metabolic diseases as well as orphan indications.